Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-231
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7504.098
uM
5.46480
6.61630
-0.7973 -0.8007 5.0000 0.3255
0.9971
1.8959
MX1
Unknown
Unknown
Bromopyruvic acid
Hexokinase II
Metabolism
12667.177
uM
0.02030
0.02529
-1.0000 -1.0000 5.0000 1.1110
0.9986
0.5892
HCC1806
TNBC
Basal A
Disulfiram
Proteasome
Proteasome
12702.174
uM
0.19098
0.16547
0.3670 0.2559 5.0000 0.3536
0.8521
1.8506
MDA-MB-361
HER2amp
Luminal
XRP44X
ELK3
MAPK
12379.157
uM
0.93556
1.07060
-0.5453 -0.4810 5.0000 0.5227
0.9875
0.4910
LY2
HR+
Luminal
Bosutinib
Src
nRTK
12319.17
uM
1.74560
2.09550
-0.7562 -0.7467 5.0000 0.4985
0.8163
0.4684
MDA-MB-436
TNBC
Basal B
Geldanamycin
HSP90
HSP90
7900.012
uM
0.00157
0.00156
-0.2721 0.0157 5.0000 0.8700
0.6184
0.8090
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7472.098
uM
6.46260
7.26350
-0.3886 -0.3967 5.0000 0.2139
0.9940
1.5098
MDA-MB-175-VII
HR+
Luminal
MG-132
Proteasome
Proteasome
10642.145
uM
0.30670
0.38133
-0.9982 -0.9855 5.0000 0.8413
0.9966
0.3537
MDA-MB-453
TNBC
Luminal
Geldanamycin
HSP90
HSP90
9723.049
uM
0.06564
0.07667
-0.5517 -0.5868 5.0000 0.8691
0.9973
0.9525
HCC1806
TNBC
Basal A
Bromopyruvic acid
Hexokinase II
Metabolism
12702.177
uM
0.09085
0.11182
-0.9173 -0.9126 5.0000 0.8363
0.9993
1.5730
MDA-MB-361
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7508.084
uM
190.85780
199.9580
-0.1308 -0.1311 5.0000 0.1752
0.9011
0.7756
HCC70
TNBC
Basal A
Nelfinavir
12714.174
uM
8.95410
11.15450
-1.0000 -1.0000 5.0000 0.3201
0.8734
0.3306
Hs 578T
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7473.074
uM
0.15419
0.18046
-0.6339 -0.5980 5.0000 0.8594
0.9948
2.5364
SUM159PT
TNBC
Basal B
AG1478
EGFR
ErbB
9042.016
uM
12.53920
8.6790
0.2330 0.4206 5.0000 0.1638
0.8252
2.8524
SUM159PT
TNBC
Basal B
AS-252424
PI3K
PI3K
11057.158
uM
inf
3.06690
0.4735 0.5788 5.0000 0.0928
0.9104
3.8594
MDA-MB-361
HER2amp
Luminal
GSK461364
PLK1
PLK
7896.001
uM
0.00127
0.00125
-0.1757 0.0463 5.0000 0.7450
0.9286
1.1912
HCC38
TNBC
Basal B
Triciribine
AKT
AKT
7468.074
uM
0.29265
0.28992
0.0167 0.0229 5.0000 0.4113
0.8951
1.5027
LY2
HR+
Luminal
Valproic acid
HDAC
HDAC
12319.143
uM
811.01570
1000.00000
-0.9998 -0.9250 5.0000 0.5128
0.8284
0.5178
HCC70
TNBC
Basal A
Vinorelbine
TUBB
TUBB
7860.042
uM
0.00826
0.00909
-0.9878 -0.3086 5.0000 0.8621
0.8125
0.6736
MDA-MB-134-VI
HR+
Luminal
GSK923295
CENPE
Kinesin
7876.001
uM
0.10556
0.11460
-0.2144 -0.2543 5.0000 0.5587
0.990
0.9806
MDA-MB-361
HER2amp
Luminal
Ispinesib
KSP
Kinesin
7508.067
uM
0.02564
0.03092
-0.9972 -0.7743 5.0000 0.9845
0.9860
0.7560
MDA-MB-175-VII
HR+
Luminal
NU6102
CDK1/2
CDK
10818.147
uM
48.72710
60.59660
-0.2276 -0.9872 5.0000 0.1847
0.8575
0.5138
HCC38
TNBC
Basal B
Disulfiram
Proteasome
Proteasome
12617.174
uM
0.19518
0.18384
-0.4690 0.1292 5.0000 0.3502
0.6974
1.5935
LY2
HR+
Luminal
Olomoucine II
CDK1
CDK
10816.147
uM
5.0970
6.34790
-0.9997 -0.9981 5.0000 0.4155
0.9979
0.7283
LY2
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7477.067
uM
6.0510
7.53770
-0.9999 -0.9998 5.0000 0.4399
0.9978
0.6787